Riskpilot← Back to searchSign inGet full accessBlommans Naturvård AB
ABIn liquidationOrg 5568430986UmeåLogging · NACE 0220Est. 20110 employees
Revenue 2025
SEK 7K
+47% vs 2024
EBITDA margin
-326.5%
-155% vs 2024
Equity ratio
18.0%
Financial strength
Net profit 2025
SEK -41K
+55% vs 2024
| Revenue | SEK 7K | +47% |
| EBITDA | SEK -22K | -155% |
| Net profit | SEK -41K | +55% |
| Total assets | SEK 275K | +20% |
| Equity | SEK 49K | -46% |
| Employees | 0 | — |
Legal name
Blommans Naturvård AB
Org number
5568430986
Legal form
Aktiebolag
NACE code
0220 · Logging
Founded
24 februari 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn Firman tecknas var för sig av externa firmatecknarna
Company purpose
Föremålet för bolagets verksamhet är att bedriva skogsentreprenad och skogsvård samt därmed förenlig verksamhet.
Address
Umeå
Email
info@heinestams.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 957 | 977 | 910 | 4 | 7 |
| Staff expenses | — | −596 | −620 | −0 | −1 |
| EBITDA | 111 | 159 | 26 | −8 | −22 |
| Depreciation & amort. | −82 | −82 | −82 | −83 | −19 |
| EBIT | 29 | 77 | −55 | −91 | −40 |
| Net financials | −9 | −4 | −1 | −1 | −1 |
| Profit before tax | 19 | 73 | −56 | −92 | −41 |
| Tax | −0 | — | — | — | — |
| Net profit | 19 | 73 | −56 | −92 | −41 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 519 | 441 | 352 | 230 | 275 |
| Equity | 166 | 240 | 183 | 91 | 49 |
| Long-term debt | 46 | 0 | — | — | — |
| Short-term debt | 307 | 202 | 169 | 139 | 226 |
| Total debt | 353 | 202 | 169 | 139 | 226 |
EBITDA margin
-326.5%
This company
15.8%
Market median
-2166% vs market
20212025
Equity ratio
18.0%
This company
38.2%
Market median
-53% vs market
20212025
Return on equity
-83.9%
This company
18.4%
Market median
-556% vs market
20212025
Net profit margin
-626.3%
This company
8.1%
Market median
-7832% vs market
20212025
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20212025
Debt / equity
4.57×
This company
0.62×
Market median
-637% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (7) | ||
EJ External Signatory | External Signatory | 2026 |
SM External Signatory | External Signatory | 2026 |
EF External Signatory | External Signatory | 2026 |
MV Liquidator | Liquidator | 2026 |
AB External Signatory | External Signatory | 2026 |
AE External Signatory | External Signatory | 2026 |
CV External Signatory | External Signatory | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Blommans Naturvård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emma Johanna Åström | External Signatory | 0 companies |
| Sofie Margareta Lundberg | External Signatory | 0 companies |
| Emma Frida Ramona Melander Vängbo | External Signatory | 0 companies |
| Mona Veronica Vesterberg | Liquidator | 0 companies |
| Anna Birgitta Emanuelsson | External Signatory | 0 companies |
| Anna Elisabeth Adolfsson | External Signatory | 0 companies |
| Camilla Viola Lind | External Signatory | 0 companies |
| Gunvor Helen Blomkvist | Deputy Board Member | 0 companies |
| Erik Stefan Blomkvist | Board of Directors | 0 companies |